Lamellar Biomedical is Diagnostic Equipment in United Kingdom that focus on cystic fibrosis business. Founded in 2007. They cover business area such as developer, complex and rare respiratory disease, anti-infective property, antibiotic, lung tissue, condition, idiopathic pulmonary fibrosis, cystic fibrosis, genetic material, pulmonary disease, doctor, transformative therapy, severe respiratory disease.
2007
( 19 years old in 2026 )
Cystic Fibrosis
-
Maxim 1, Level 2, Suites 1 & 5
2 Parklands Way Eurocentral, North Lanarkshire
Holytown ML1 4WR
Scotland, United Kingdom
Private
developercomplex and rare respiratory diseaseanti-infective propertyantibioticlung tissueconditionidiopathic pulmonary fibrosiscystic fibrosisgenetic materialpulmonary diseasedoctortransformative therapysevere respiratory disease
* We use standard office opening hours in near Lamellar Biomedical's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Lamellar Biomedical is Diagnostic Equipment business from United Kingdom that founded in 2007 (19 years old in 2026), Lamellar Biomedical business is focusing on Cystic Fibrosis.
Lamellar Biomedical headquarter office and corporate office address is located in Maxim 1, Level 2, Suites 1 & 5 2 Parklands Way Eurocentral, North Lanarkshire Holytown ML1 4WR Scotland, United Kingdom.
Lamellar Biomedical was founded in United Kingdom.
In 2026, Lamellar Biomedical is currently focus on cystic fibrosis sector.
Above is snippet of Google Trends for "cystic fibrosis" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Lamellar Biomedical, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.